FDA Approves Drug for Treatment of Aggressive Brain Cancer

[News Reader]

The U.S. Food and Drug Administration recently approved Avastin (bevacizumab) to treat patients with glioblastoma multiforme (GBM) when this form of brain cancer continues to progress following standard therapy.

More... (http://www.fda.gov/bbs/topics/NEWS/2009/NEW02014.html)